New pain drug shows promise in small tummy tuck study
NCT ID NCT04182880
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 2a study tested an experimental drug called CPL-01 in 20 people who had mini-abdominoplasty (a type of tummy tuck). The goal was to see if the drug is safe and how it behaves in the body after surgery. Participants received either CPL-01 or a placebo, and researchers measured drug levels in the blood over several days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CPL-01 (an experimental painkiller)
- What this could lead to
- If it works, this could lead to a new option for managing pain after surgery with fewer side effects.
- What could go wrong
- This is a small, early-phase study (20 people) focused on safety and drug levels, not on how well it works. The results may not apply to larger groups or other surgeries.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABDOMINOPLASTY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chesapeake Research Group
Pasadena, Maryland, 21122, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.